Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | 0.00% | 0.00% | -14.29% |
16/05 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
25/03 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.29% | 6.26M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial